These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 16176205

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O, Lynge J, Endahl L, Damholt B, Nosek L, Heise T.
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [Abstract] [Full Text] [Related]

  • 23. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
    Mostad IL, Bjerve KS, Basu S, Sutton P, Frayn KN, Grill V.
    Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
    [Abstract] [Full Text] [Related]

  • 24. Hormonal, subjective, and neurocognitive responses to brief hypoglycemia in postmenopausal women and age-matched men with type 2 diabetes mellitus.
    Bremer JP, Baron M, Peters H, Oltmanns KM, Kern W, Fehm HL, Born J, Schultes B.
    Metabolism; 2006 Mar; 55(3):331-8. PubMed ID: 16483876
    [Abstract] [Full Text] [Related]

  • 25. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y, DeFronzo RA.
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [Abstract] [Full Text] [Related]

  • 26. Hormone and metabolic profiles in children and adolescents with type I diabetes mellitus.
    MacGillivray MH, Voorhess ML, Putnam TI, Li PK, Schaefer PA, Bruck E.
    Diabetes Care; 1982 Dec; 5 Suppl 1():38-47. PubMed ID: 6821306
    [Abstract] [Full Text] [Related]

  • 27. Type 2 diabetic patients may have a mild form of an injury response: a clinical research center study.
    Richardson AP, Tayek JA.
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1286-90. PubMed ID: 12006358
    [Abstract] [Full Text] [Related]

  • 28. Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Laager R, Keller U.
    Diabetologia; 1993 Oct; 36(10):966-71. PubMed ID: 8243878
    [Abstract] [Full Text] [Related]

  • 29. [Influence of insulinfree rehydration on diabetic derangements (author's transl)].
    Kleinberger G.
    Wien Klin Wochenschr; 1980 Sep 12; 92(17):616-29. PubMed ID: 7006220
    [Abstract] [Full Text] [Related]

  • 30. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
    Pfützner J, Forst T, Butzer R, Forst S, Weber MM, Pfützner AH, Pfützner A.
    Diabet Med; 2006 Oct 12; 23(10):1124-9. PubMed ID: 16978378
    [Abstract] [Full Text] [Related]

  • 31. Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus.
    Ferderbar S, Pereira EC, Apolinário E, Bertolami MC, Faludi A, Monte O, Calliari LE, Sales JE, Gagliardi AR, Xavier HT, Abdalla DS.
    Diabetes Metab Res Rev; 2007 Jan 12; 23(1):35-42. PubMed ID: 16634125
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H, Uchigata Y, Iwamoto Y, Imagawa A, Iwahashi H, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Hanafusa T, Makino H.
    Ann Med; 2008 Jan 12; 40(5):395-400. PubMed ID: 18484350
    [Abstract] [Full Text] [Related]

  • 34. A 48-year-old man with uncontrolled diabetes.
    Hu M, Isaacson JH.
    Cleve Clin J Med; 2009 Jul 12; 76(7):413-6. PubMed ID: 19570974
    [No Abstract] [Full Text] [Related]

  • 35. Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention.
    Boden G, Homko C, Mozzoli M, Zhang M, Kresge K, Cheung P.
    Diabetes; 2007 Jan 12; 56(1):248-55. PubMed ID: 17192489
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients.
    Malchoff CD, Pohl SL, Kaiser DL, Carey RM.
    Am J Med; 1984 Aug 12; 77(2):275-85. PubMed ID: 6431813
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Admissions for diabetic ketoacidosis in ethnic minority groups in a city hospital.
    Nyenwe E, Loganathan R, Blum S, Ezuteh D, Erani D, Palace M, Ogugua C.
    Metabolism; 2007 Feb 12; 56(2):172-8. PubMed ID: 17224329
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.